Senti Biosciences Announces Executive Team Reshuffle and New CFO
Company Announcements

Senti Biosciences Announces Executive Team Reshuffle and New CFO

Senti Biosciences (SNTI) just unveiled an announcement.

Senti Biosciences, Inc. has announced significant changes in its executive team: Timothy Lu, the CEO and President, is taking over as the interim principal financial and accounting officer from May 4, 2024, until a permanent replacement is found or until he departs from the role. Yvonne Li steps in as the Interim Chief Financial Officer on the same date, after the filing of the company’s quarterly report. Li’s appointment comes with a consulting agreement that offers her $350 per hour up to $370,000. These strategic appointments aim to strengthen the company’s financial leadership.

For a thorough assessment of SNTI stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlySenti Bio announces execution of grant award from CIRM for developing SENTI-202
TheFlySenti Biosciences Inc trading halted, news pending
TheFlySenti Bio announces 1-for-10 reverse stock split
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App